Bristol-Myers Squibb Company (BMY)
NYSE · Healthcare
Bristol-Myers Squibb Company Cash Flow 2007–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Operating Cash Flow | 14.16B | 15.19B | 13.86B | 13.07B | 16.21B | 14.05B | 8.21B | 7.07B | 5.28B | 3.06B | 2.10B | 3.15B | 3.54B | 6.94B | 4.84B | 4.49B | 4.07B | 3.71B | 3.15B |
| Depreciation & Amort. | 4.01B | 9.60B | 9.76B | 10.28B | 10.69B | 10.38B | 1.75B | 637.0M | 789.0M | 382.0M | 376.0M | 467.0M | 763.0M | 681.0M | 628.0M | 607.0M | — | — | — |
| Investing Activities | |||||||||||||||||||
| Capital Expenditure | 1.31B | 1.25B | 1.21B | 1.12B | 973.0M | 753.0M | 836.0M | 951.0M | 1.05B | 1.22B | 820.0M | 526.0M | 537.0M | 548.0M | 367.0M | 424.0M | 730.0M | 941.0M | 843.0M |
| Free Cash Flow | 12.85B | 13.94B | 12.65B | 11.95B | 15.23B | 13.30B | 7.37B | 6.12B | 4.22B | 1.84B | 1.28B | 2.62B | 3.01B | 6.39B | 4.47B | 4.07B | 3.33B | 2.77B | 2.31B |
| Financing Activities | |||||||||||||||||||
| Dividends Paid | 5.04B | 4.86B | 4.74B | 4.63B | 4.40B | 4.08B | 2.68B | 2.61B | 2.58B | 2.55B | 2.48B | 2.40B | 2.31B | 2.29B | 2.25B | 2.20B | 2.48B | 2.46B | 2.21B |
| Stock Buybacks | 0 | 0 | 5.16B | 8.00B | 6.29B | 1.55B | 7.30B | 320.0M | 2.47B | 231.0M | — | — | 433.0M | 2.40B | 1.22B | 576.0M | — | — | — |
Bristol-Myers Squibb Company Cash Flow — FAQ
Bristol-Myers Squibb Company (BMY) cash flow over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BMY's cash flow history?
The chart and table above show Bristol-Myers Squibb Company's cash flow by year and by quarter, including the growth rate.